Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Thursday 04 April 2024 7:51 pm  |  Updated:  Sunday 07 April 2024 8:23 pm

‘Local health reforms don’t work’ as a third struggle to access GP, warns expert

By: Laura Forsyth

Add as a preferred source on Google
Changing local health services by increasing the role of local pharmacies has failed to improve patient care, an expert warns.
Changing local health services by increasing the role of local pharmacies has failed to improve patient care, an expert warns.

Changing local health services by increasing the role of local pharmacies over using a GP has failed to improve patient care, an expert warns.

New official figures from the Office for National Statistics (ONS) cast doubt on the effectiveness of the Government’s new community healthcare plans.

They reveal that 30.9 per cent of patients found it difficult or very difficult to access their GP surgery during January and February. 19.7 per cent of patients who contacted their local practice rated their experience as fairly or very poor.

Dr Avinash Hari Narayanan, clinical lead at London Medical Laboratory, says: “Local medical services are always pushed hard in January and February, but one of the disappointing things to emerge from the latest figures is that changes in the way we access local healthcare are not having a notable impact.

“The results also reveal that 8.5 per cent of people trying to contact their GP failed to make contact entirely and 11.5 per cent took two or more days before they succeeded. Of those, 12 per cent were given appointments over two weeks after contact.

“Disappointingly, only 4.5 per cent of patients were able to book their GP or practice appointment through the NHS App. Clearly, more needs to be done to integrate local practices with this service, which has the potential to transform access.

“More disappointingly still, given the new wider role community pharmacies have been given in diagnosing and prescribing for certain conditions, only 2.6 per cent of patients were recommended to go straight to their pharmacy.

“People need to know that community pharmacies can now speed up treatments and take the pressure off surgeries by directly prescribing medications for certain conditions.”

Local pharmacies can now supply prescription-only treatment, if they believe it’s needed, for the following conditions: 

  • Sinusitis (for patients aged 12 years and over only)
  • Sore throat (aged 5+)
  • Earache (aged 1-17 years)
  • Infected insect bite (aged 1 year+)
  • Impetigo (aged 18 years+)
  • Shingles (aged 18 years+)
  • Urinary tract infections (women aged 16 to 64) 

Dr Narayanan added: “Clearly, more needs to be done to increase the public’s awareness of these new services, thereby alleviating pressure on GP practices. However, we should not be too quick to worry about access to healthcare. While these latest figures look alarming and, indeed, are concerning, 72.5 per cent of determined patients did manage to contact their GP practice on the same day and 64.3 per cent rated their experience as very or fairly good.”

Read more

cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Wellness

People & Organisations

  • London Medical Laboratory
  • Office for National Statistics

Related Topics

  • Health

Trending Articles

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • As it happened: Stocks tumble after Apple rattles global markets; UK food exports hit by US tariffs

  • Barclays and Lloyds join banking sector plan for digital ID

More from City PM

  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions

    Business Wire
  • Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

    Business Wire
  • LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

    Business Wire
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • Mosaic Clinical Technologies™ Launches Mosaic Reporting™, an AI-Native Reporting Platform Built for Radiology Workflows

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Award winning Medtech firm excels again

    Partner
    Unable to generate alt text without specific article content or context. Please provide more details or context.

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy